Shed, a telehealth wellness company founded to deliver personalized treatments for common health concerns, has added a Hair Solutions vertical that combines prescription oral medications and topical formulations aimed at the biological drivers of hair thinning and loss. Chief executive Morley Baker said the products are intended to go beyond cosmetic coverage by targeting hormonal imbalance, inflammation, restricted blood flow, and inadequate nutrient delivery—factors the company identifies as central to pattern baldness and stress-related shedding.
The new line supplies once-daily oral capsules and high-potency scalp solutions that can be prescribed in combination. For male patients, the capsules may include finasteride and supporting nutrients, while the topical option pairs minoxidil with tretinoin and other active agents designed to improve absorption and follicle stimulation. Formulas for women substitute spironolactone for finasteride and provide an alternate serum containing copper peptides for customers who prefer a gentler approach.
Shed’s service begins with an online medical questionnaire that is reviewed by a licensed clinician. Approved users receive a treatment plan and ongoing refills shipped directly to their homes, and can message the clinical team to adjust the concentration or switch components if side-effects occur. The company states that its multi-pathway strategy is suitable for early shedding, postpartum loss, and longer-term androgenic alopecia, but emphasizes that individual response varies and that consistent use over several months is required for measurable results.